非侵入式眼表综合分析仪可无创性评估干眼患者的眼表情况

基础医学与临床 ›› 2020, Vol. 40 ›› Issue (10): 1358-1361.

非侵入式眼表综合分析仪可无创性评估干眼患者的眼表情况

陈国玲^1*, 王兴富², 韩宜平¹, 鲍印磊¹, 刘少华¹, 马广凤¹

1.山东大学第二医院眼科, 山东济南 250033;
2.潍坊工程职业学院后勤服务处, 山东潍坊 262500

收稿日期:2020-05-08 修回日期:2020-08-16 出版日期:2020-10-05 发布日期:2020-09-29
通讯作者: ^* cgl6129@163.com
基金资助:
山东省重点研发计划项目(2018GSF118081)

Noninvasive ocular surface analyzer evaluates non-aggressively the ocular surface of patients with dry eye disease

CHEN Guo-ling^1*, WANG Xing-fu², HAN Yi-ping¹, BAO Yin-lei¹, LIU Shao-hua¹, MA Guang-feng¹

1. Department of Ophthalmology, the Second Hospital of Shandong University, Jinan 250033;
2. Department of Service, Weifang Engineering Vocational College, Weifang 262500, China

Received:2020-05-08 Revised:2020-08-16 Online:2020-10-05 Published:2020-09-29
Contact: ^* cgl6129@163.com

摘要/Abstract

摘要： 目的探讨非侵入式眼表综合分析仪用于评估干眼(DED)患者眼表情况的临床意义。方法 DED患者50例(50只眼)作为DED组,健康志愿者50名(50只眼)作为对照组。依次进行病史询问、眼表疾病指数(OSDI)问卷调查;非侵入式眼表综合分析仪检查非侵入性首次泪膜破裂时间(NIBUTf)及睑板腺情况;裂隙灯显微镜观察睑缘、角膜荧光素染色(CFS)及泪膜破裂时间(FBUT)。结果 DED组OSDI分值较对照组高(P＜0.01);NIBUTf与FBUT呈正相关(均P＜0.01);DED组NIBUTf和FBUT均较对照组低,而睑板腺缺失(MGL)评分和CFS均较对照组高(P＜0.01);NIBUTf与OSDI及MGL评分均呈负相关(P＜0.01)。结论非侵入式眼表综合分析仪可无创性检测泪膜稳定性和睑板腺缺失情况,对客观评估干眼患者的眼表情况具有重要临床意义。

关键词: 眼表, 干眼, 泪膜, 睑板腺

Abstract: Objective To evaluate the clinical use of noninvasive ocular surface analyzer in checking the ocular surface of dry eye disease (DED) patients. Methods A total of 100 eyes were covered in this study, in which 50 eyes were from DED patients (named DED group) and 50 eyes were from healthy volunteers(named control group). All subjects completed following examinations and tests: detailed medical history, ocular surface disease index (OSDI) questionnaire, the first noninvasive tear breakup time(NIBUTf) and morphological characteristics of meibomian glands examined by a noninvasive ocular surface analyzer, tear breakup time by fluorescein (FBUT),corneal fluorescein staining (CFS),the eyelid, and ocular surface organization checked by the slit lamp micros-cope. Results Compared with the control group, OSDI score of DED group was significantly higher (P＜0.01). NIBUTf had a positive correlation with FBUT(P＜0.01). The NIBUTf and FBUT were shorter, while the scores of meibomian gland loss (MGL) and CFS were higher in DED group (all P＜0.01). NIBUTf had a negative correlation with MGL score and OSDI score (all P＜0.01). All subjects accepted the examinations with signed the informed consent form, and the same examination was performed by the same inspector. Conclusions The non-inva- sive ocular surface analyzer may detect the tear film stability and meibomian gland loss by a non-contact way, and it has important clinical potential to evaluate the ocular surface of dry eye patients objectively.

Key words: ocular surface, dry eye disease, tear film, meibomian gland

中图分类号:

R772.2

陈国玲, 王兴富, 韩宜平, 鲍印磊, 刘少华, 马广凤. 非侵入式眼表综合分析仪可无创性评估干眼患者的眼表情况[J]. 基础医学与临床, 2020, 40(10): 1358-1361.

CHEN Guo-ling, WANG Xing-fu, HAN Yi-ping, BAO Yin-lei, LIU Shao-hua, MA Guang-feng. Noninvasive ocular surface analyzer evaluates non-aggressively the ocular surface of patients with dry eye disease[J]. Basic & Clinical Medicine, 2020, 40(10): 1358-1361.

参考文献

[1] 中华医学会眼科学分会角膜病学组.干眼临床诊疗专家共识(2013年)[J].中华眼科杂志,2013,49:73-75.
[2] Craig JP, Nichols KK, Akpek EK,et al.TFOS DEWS Ⅱ definition and classification report[J].Ocul Surf, 2017,15:276-283.
[3] 亚洲干眼协会中国分会. 海峡两岸医药交流协会眼科专业委员会眼表与泪液病学组.我国睑板腺功能障碍诊断与治疗专家共识(2017年)[J].中华眼科杂志,2017,53:657-661.
[4] Wolffsohn JS,Arita R,Chalmers R,et al.TFOS DEWS Ⅱ diagnostic methodology report[J]. Ocul Surf, 2017,15:539-574.
[5] Köksoy Vayisogğlu S,Öncü E,Dursun Ö,et al. Investiga-tion of dry eye symptoms in lecturers by ocular surface disease index[J].Turk J Ophthalmol,2019,49: 142-148.
[6] Ozcura F, Aydin S, Helvaci MR.Ocular surface disease index for the diagnosis of dry eye syndrome[J]. Ocul Immunol Inflamm, 2007,15: 389-393.
[7] 庄文娟.眼表疾病[M] //赵勘兴,杨培增,范先群.眼科学(第九版).北京:人民卫生出版社,2018:78-85.
[8] Willcox MDP, Argüeso P,Georgiev GA,et al.TFOS DEWS Ⅱ tear film report[J]. Ocul Surf,2017,15:366-403.
[9] Chhadva P,Goldhardt R,Galor A.Meibomian gland disease: the role of gland dysfunction in dry eye disease[J]. Ophthalmology,2017,124: S20-S26.
[10] Miller KL,Walt JG, Mink DR, et al.Minimal clinically important difference for the ocular surface disease index[J].Arch Ophthalmol,2010,128:94-101.
[11] Wang MTM,Craig JP.Comparative evaluation of clinical methods of tear film stability assessment:A randomized crossover trial[J].JAMA Ophthalmol,2018, 136: 291-294.
[12] Llorens Quintana C,Rico Del Viejo L,Syga P, et al.Meibomian gland morphology:the influence of structural variations on gland function and ocular surface parameters[J]. Cornea, 2019, 38:1506-1512.